Earnings Call · Q1 FY2022·2022-05-09

Q1 22EPS +2.86%·Rev n/aQ4 21EPS +23.53%·Rev n/aQ3 21EPS +11.76%·Rev n/aQ2 21EPS +7.69%·Rev n/a⚠ consensus missing

Elanco Animal Health Inc ELAN

Katy Grissom — Head of Investor Relations

Jeffrey Simmons — President and Chief Executive Officer

Todd Young — Chief Financial Officer

−8.2%1d on move date−5.0% vs SPY3d−12.5%5d−6.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ELAN calls or request research access.

More ELAN calls Browse calls Request research access